I personally think getting any results from any of the phase 3 COVID trials before the end of the year is quite fanciful. Not Team Dimerix's fault. If anything it goes to show how well Team Dimerix did last year to deliver 2x Phase 2 trials on time and budget last year during the COVID madness whilst others are having delays and blowouts. I'm still backing Nina and management
DXB Chart, page-109
-
- There are more pages in this discussion • 1,514 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $217.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 38.0¢ | $275.3K | 716.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 72085 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 38980 | 4 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |